China Pharmaceutical Raw Material CAS 82410-32-0 Ganciclovir Powder, Find details about China Ganciclovir, Ganciclovir Powder from Pharmaceutical Raw Material CAS 82410-32-0 Ganciclovir Powder
Pharmaceutical Raw Material CAS 82410-32-0 Ganciclovir Powder | |
Product Name | Ganciclovir |
CAS | 82410-32-0 |
MF | C9H13N5O4 |
MW | 255.23 |
Assay | 99% Min. |
Appearance | White Crystalline Solid |
Ganciclovir is an antiviral. It is used to treat infections caused by viruses.
Ganciclovir is used to treat the symptoms of cytomegalovirus (CMV) infection of the eyes in people whose immune system is not working fully. This includes patients with acquired immune deficiency syndrome (AIDS). Ganciclovir will not cure this eye infection, but it may help to keep the symptoms from becoming worse. It is also used to help prevent CMV infection in patients who receive organ or bone marrow transplants, as well as in patients with advanced human immunodeficiency virus (HIV) infection
Medical use
Ganciclovir is indicated for:
It is also used for acute CMV colitis in HIV/AIDS and CMV pneumonitis in immunosuppressed patients.
Ganciclovir has also been used with some success in treating Human herpesvirus 6 infections.[3]
Ganciclovir has also been found to be an effective treatment for herpes simplex virus epithelial keratitis.[4]
Ganciclovir is commonly associated with a range of serious haematological adverse effects. Common adverse drug reactions (≥1% of patients) include: granulocytopenia, neutropenia, anaemia, thrombocytopenia, fever, nausea, vomiting, dyspepsia, diarrhea, abdominal pain, flatulence, anorexia, raised liver enzymes, headache, confusion, hallucination, seizures, pain and phlebitis at injection site (due to high pH), sweating, rash, itch, increased serum creatinine and blood urea concentrations.
Ganciclovir is considered a potential human carcinogen, teratogen, and mutagen. It is also considered likely to cause inhibition of spermatogenesis. Thus, it is used judiciously and handled as a cytotoxic drug in the clinical setting.
Related ProductsBenzocaine hydrochloride | CAS:23239-88-5 |
Tetracaine hydrochloride | CAS:136-47-0 |
Procaine | CAS:59-46-1 |
Tetracaine | CAS:94-24-6 |
Pramoxine Hydrochloride | CAS:637-58-1 |
Procaine HCl | CAS:51-05-8 |
Lidocaine | CAS:137-58-6 |
Dibucaine hydrochloride | CAS:61-12-1 |
Prilocaine | CAS:721-50-6 |
Propitocaine hydrochloride | CAS:1786-81-8 |
Proparacaine hydrochloride | CAS:5875-06-9 |
Lidocaine hydrochloride | CAS:73-78-9 |
Articaine hydrochloride | CAS:23964-57-0 |
Levobupivacaine hydrochloride | CAS:27262-48-2 |
Ropivacaine hydrochloride | CAS:132112-35-7 |
Bupivacaine | CAS:2180-92-9 |
Bupivacaine hydrochloride | CAS:14252-80-3 |
Items | Specifications |
Appearance | Off-white to white powder |
Related Substances | Any single unknown impurity≤0.1% Total impurities:≤0.5% |
Enantiomer | <0.5% |
Loss on drying | Not more than 0.5% |
Melting Point | 154~158ºC |
Residue on ignition | Not more than 0.5% |
Residual solvents | Methanol <3000ppm Ethanol <5000ppm THF<720ppm Acetonitrile<410ppm Acetone <5000ppm Dichloromethane <600ppm |
Purity(HPLC) | ≥99% |
Results | The product conforms to the above specifications. |